Back to Hudson Bay Capital Management LP

BMRN
Showing 8 of 30 quarters

Position history for Hudson Bay Capital Management LP's holdings in BIOMARIN PHARMACEUTICAL INC

Hudson Bay Capital Management LP holds 974,776 shares of BMRN (BIOMARIN PHARMACEUTICAL INC), worth $55.1M as of 2026-Q1. The position was increased (+45.5% shares). BMRN represents 0.2% of Hudson Bay Capital Management LP's portfolio.

Current Value

$55.1M

Current Shares

974,776

Total Value Change

+$34.9M

Total Shares Change

+730,076

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
974,776
+45.5%
$55.1M0.2%$58.53
48
2025-Q4
Decreased
670,002
-3.4%
$39.8M0.1%$58.99
0
2025-Q3
Increased
693,894
+31.8%
$37.6M0.1%$54.02
44
2025-Q2
Decreased
526,420
-10.3%
$28.9M0.1%$55.17
0
2025-Q1
Increased
586,845
+27.6%
$41.5M0.1%$71.44
43
2024-Q4
Increased
460,000
+4.3%
$30.2M0.1%$65.45
36
2024-Q3
Increased
441,200
+80.3%
$31M0.1%$70.58
53
2024-Q2
Increased
244,700
+122.7%
$20.1M0.1%$82.33
46

Other major holders of BMRN: Capital Research Global Investors, PRIMECAP MANAGEMENT CO/CA/, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used